跳至主要内容
临床试验/DRKS00027559
DRKS00027559已完成1 期

Intraoperative Pancreatic Leakage Indicator – Post Market Confirmatory Study (PMCF, IDEAL Stage I) - ViP

Magle Chemoswed AB0 个研究点目标入组 30 人开始时间: 2022年3月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Planned partial pancreatectomy for any indication including minimally invasive and open distal pancreatectomy and partial pancreatoduodenectomy
  • 2. Age = 18 years
  • 3. Ability of subject to understand character and individual consequences of the clinical trial.
  • 4. Willing and able to give written informed consent for participation in the investigation

排除标准

  • 1. American Society of Anesthesiologists (ASA) Score > 3
  • 2. Pregnancy or lactation
  • 3. Allergy or known intolerability to bromothymol blue or potato starch
  • 4. Participation in another interventional trial with interference of intervention or outcome of this study
  • 5. Any condition which could result in an undue risk for the patient in the opinion of the investigator
  • 6. Expected lack of compliance or language problems

研究者

发起方
Magle Chemoswed AB

相似试验